[1] PREDA CM, POPESCU CP, BAICUS C, et al. Risk of hepatitis B virus reactivation in hepatitis B virus+hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r+dasabuvir+ribavirin[J]. J Viral Hepat, 2018, 25(7): 834. doi: 10.1111/jvh.12872
[2] 胡华华, 刘俊, 关丽愉, 等. 影响肝硬化合并食管胃底静脉曲张破裂出血的血流动力学分析[J]. 肝脏, 2020, 25(4): 369.
[3] 杨连粤, 白雪莉. 肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2019版)[J]. 中国实用外科杂志, 2019, 39(12): 1241.
[4] ZHAO W, XUE N, CUI P, et al. Plasma YAP1 predicts esophageal varices and the risk of variceal bleeding in liver cirrhosis[J]. Biomark Med, 2021, 15(15): 1411. doi: 10.2217/bmm-2020-0573
[5] BRUNNER F, BERZIGOTTI A, BOSCH J. Prevention and treatment of variceal haemorrhage in 2017[J]. Liver Int, 2017, 37(S1): 104.
[6] 李春, 张林, 黄永, 等. 乙型肝炎肝硬化失代偿期合并食管胃底静脉曲张患者选择不同治疗方案对生活质量的影响[J]. 现代医药卫生, 2021, 37(18): 3170. doi: 10.3969/j.issn.1009-5519.2021.18.029
[7] 叶东, 张俊霞, 李洁, 等. 内镜下食管静脉曲张套扎术治疗乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者再出血风险观察[J]. 实用肝脏病杂志, 2021, 24(6): 879. doi: 10.3969/j.issn.1672-5069.2021.06.028
[8] WANG AJ, ZHENG XL, HONG JB, et al. Correction to: cap-assisted endoscopic sclerotherapy vs ligation in the long-term management of medium esophageal varices: a randomized trial[J]. Clin Transl Gastroenterol, 2021, 12(2): e00318. doi: 10.14309/ctg.0000000000000318
[9] 刘立楠. 肝硬化患者上消化道出血危险因素与预后影响因素分析[J]. 医学信息, 2021, 34(14): 3.
[10] FOUAD TR, ABDELSAMEEA E, ABDEL-RAZEK W, et al. Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post-therapeutic outcome and prognostic indicators[J]. J Gastroenterol Hepatol, 2019, 34(9): 1604. doi: 10.1111/jgh.14659
[11] 张妍, 丁惠国. 肝硬化食管静脉曲张内镜治疗术后早期再出血的危险因素分析[J]. 临床肝胆病杂志, 2021, 37(9): 2087. doi: 10.3969/j.issn.1001-5256.2021.09.017
[12] LI CJ, YANG ZH, LU FG, et al. Clinical significance of fibrotic, haemostatic and endotoxic changes in patients with liver cirrhosis[J]. Acta Gastroenterol Belg, 2018, 81(3): 404.
[13] 陈冬华. PT、Fg、PLT检测对肝硬化失代偿期患者出血的监控预警作用[J]. 实验与检验医学, 2021, 39(4): 999. doi: 10.3969/j.issn.1674-1129.2021.04.071
[14] 胡娜, 叶长根, 戴华梅, 等. 食管胃底静脉曲张破裂出血的内镜下治疗效果[J]. 中国现代医生, 2021, 59(29): 60.
[15] 江秋维, 黄理, 姚朝光. 乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者临床特征及其危险因素分析[J]. 实用肝脏病杂志, 2021, 24(4): 532. doi: 10.3969/j.issn.1672-5069.2021.04.020
[16] JAKAB SS, GARCIA-TSAO G. Evaluation and management of esophageal and gastric varices in patients with cirrhosis[J]. Clin Liver Dis, 2020, 24(3): 335. doi: 10.1016/j.cld.2020.04.011
[17] 李莹. 不同手术方案对肝硬化伴食管胃静脉曲张破裂出血患者预后及生存状况的影响[J]. 当代医学, 2021, 27(27): 34. doi: 10.3969/j.issn.1009-4393.2021.27.013
[18] GARCIA-TSAO G, ABRALDES JG, BERZIGOTTI A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology, 2017, 65(1): 310. doi: 10.1002/hep.28906
[19] 徐小元, 丁惠国, 贾继东, 等. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 实用肝脏病杂志, 2016, 19(5): 641.
[20] 佘倩, 陈明锴, 肖勇, 等. 肝硬化并食管胃静脉曲张二级预防胃镜复查必要性及依从性的临床研究[J]. 中国内镜杂志, 2020, 26(7): 13.